Adjusted EPS beat expectations and guidance rose, despite a modest revenue miss

Expectations called for roughly $2.12 of adjusted EPS and $341 million of revenue. The quarter delivered $2.20 of adjusted EPS but $339.0 million of sales, making this an earnings beat alongside a small revenue shortfall. The published EPS estimate was about $2.12, while the available revenue estimate was approximately $341 million.

The quality of the quarter was stronger than the headline revenue miss suggests. Sales rose 14%, while adjusted EBIT increased 19% and margin expanded 90 basis points, indicating operating leverage rather than growth purchased solely through acquisitions. Aerospace & Defense was the main contributor, with revenue up to $168.2 million from $136.3 million and adjusted EBIT up to $50.5 million from $39.3 million (Segment Results — Aerospace & Defense). USG revenue grew modestly, while Test revenue was nearly flat (Segment Results — USG and Test).

Management raised full-year FY2026 guidance, providing the clearest incremental positive signal. The release says guidance was raised again, but the supplied filing text does not include the updated numerical revenue or adjusted-EPS ranges, so the size of the increase cannot be assessed precisely (Management Commentary). That matters because the quarter's EPS beat was meaningful, but the modest revenue miss means the guidance change is what determines whether expectations for the full year have genuinely moved higher.

Backlog and orders reinforce the forward picture. Ending backlog reached $1.541 billion, up from $1.134 billion at the start of the fiscal year, while nine-month entered orders totaled $1.345 billion (Backlog and Entered Orders — YTD). The increase was broad, led by Aerospace & Defense, and provides support for continued above-market growth; however, backlog is not revenue and still depends on execution and delivery timing.

Cash generation improved in continuing operations, but the balance sheet still reflects acquisition-related complexity. Cash from continuing operating activities reached $193.4 million versus $88.3 million a year earlier, while long-term debt fell to $65.0 million from $166.0 million at fiscal year-end (Cash Flow Statement; Balance Sheet). Consolidated cash declined to $73.2 million because discontinued operations used $59.3 million and financing activities absorbed $119.2 million (Cash Flow Statement). Net, the filing lands as narrowly better than expected: the EPS beat, margin expansion, backlog growth, stronger continuing cash flow, and raised guidance outweigh the small revenue miss, though the absent numerical guidance update limits precision.